News room

Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment

Press releases

2022

8 November, 2022
News
English
Regulatory
MAR
Report
Interim
Q3
IR
Optional
25 October, 2022
News
Corporate Information
Nomination Committee
English
Regulatory
Listing Regulation
IR
Optional
19 August, 2022
News
English
Regulatory
MAR
VPML
Report
Interim
Q2
IR
Optional
31 May, 2022
News
Corporate Action
Shares
English
Regulatory
LHFI
IR
Optional
30 May, 2022
News
Corporate Information
General meeting
Report of the AGM
English
Regulatory
Listing Regulation
IR
Optional
19 May, 2022
News
Corporate Action
Shares
Issuance
English
Regulatory
MAR
IR
Optional
28 April, 2022
News
Corporate Action
Prospectus
English
Regulatory
Listing Regulation
IR
Optional
26 April, 2022
News
English
Regulatory
MAR
Report
Interim
Q1
IR
Optional
20 April, 2022
News
English
Regulatory
VPML
Report
Annual
IR
Optional
13 April, 2022
News
Corporate Information
General meeting
Report of the AGM
English
Regulatory
Listing Regulation
IR
Optional
21 March, 2022
News
Corporate Information
General meeting
Notice
English
Regulatory
Listing Regulation
IR
Optional
21 March, 2022
News
Corporate Action
Shares
Issuance
English
Regulatory
MAR
IR
Optional
17 February, 2022
News
English
Regulatory
MAR
Report
Interim
Yearend
IR
Optional
18 January, 2022
News
Corporate Information
Other Corporate Information
English
Regulatory
MAR
IR
mfn-cus-emcitate

2021

13 December, 2021
News
Corporate Information
Other Corporate Information
English
Regulatory
MAR
IR
mfn-cus-emcitate
5 November, 2021
News
Corporate Information
Nomination Committee
English
Regulatory
Listing Regulation
IR
4 November, 2021
News
English
Regulatory
MAR
Report
Interim
Q3
IR
19 August, 2021
News
English
Regulatory
MAR
VPML
Report
Interim
Q2
IR
mfn-cus-aladote
24 May, 2021
News
Corporate Information
Other Corporate Information
English
Regulatory
Listing Regulation
IR
17 May, 2021
News
Corporate Information
Other Corporate Information
English
Regulatory
Listing Regulation
IR
29 April, 2021
News
Corporate Information
General meeting
Report of the AGM
English
Regulatory
Listing Regulation
IR
22 April, 2021
News
English
Regulatory
Listing Regulation
Report
Interim
Q1
IR
19 April, 2021
News
Corporate Information
Staff change
English
Regulatory
MAR
IR
30 March, 2021
News
English
Regulatory
VPML
Report
Annual
IR
26 March, 2021
News
Corporate Information
Nomination Committee
English
Regulatory
Listing Regulation
IR

Calendar and upcoming reports

December 15, 2022
DNB Nordic Healthcare Conference

February 22, 2023
Year-end Report Q4 2022

Show more events

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com